Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study
- PMID: 32241798
- DOI: 10.1136/annrheumdis-2020-217013
Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study
Abstract
Background: Idiopathic thrombocytopenic purpura (ITP) may play a role in early-stage systemic lupus erythematosus (SLE). The incidence of SLE in patients with ITP and the potential relationship between them is still unclear. This study was performed to provide epidemiological evidence regarding the relationship between ITP and SLE occurrence.
Methods: In this population-based retrospective cohort study, the risk of SLE was analysed in a cohort of patients newly diagnosed with ITP between 2000 and 2013. Controls were selected at a 1:2 ratio through propensity score matching (PSM) using the greedy algorithm. The Cox proportional hazard model was used to analyse the association between ITP and SLE incidence. There were four different Cox regression models, and the sensitivity analyses were implemented to evaluate the HR of SLE after exposure with ITP.
Results: In the age-matched and sex-matched ITP and non-ITP cohort, the average follow-up time was about 80 months in this study. There were 34 (4.70%) and 27 (0.19%) incident cases of SLE in ITP and non-ITP group. The incidence rates were 62.0 (95% CI 44.3 to 86.8) and 2.10 (95% CI 1.44 to 3.06), respectively. The adjusted HR of incidental SLE in the ITP group was 25.1 (95% CI 13.7 to 46.0). The other risk factors for SLE were female sex and Sjogren's syndrome. After PSM, the incidence rate and Kaplan-Meir curves of SLE were consistent with the results for the age-matched and sex-matched population, the HR 17.4 (95% CI 5.28 to 57.4) was estimated by conditional Cox model.
Conclusion: This cohort study demonstrated that patients with ITP have a higher risk of SLE. Clinically, patients with ITP should be monitored for incidental lupus.
Keywords: autoimmune diseases; epidemiology; systemic lupus erythematosus.
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Population-based studies in systemic lupus erythematosus: immune thrombocytopenic purpura or 'blood-dominant' lupus?Ann Rheum Dis. 2020 Jun;79(6):683-684. doi: 10.1136/annrheumdis-2020-217356. Epub 2020 Apr 20. Ann Rheum Dis. 2020. PMID: 32312772 No abstract available.
-
Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopaenic purpura.Ann Rheum Dis. 2022 May;81(5):e81. doi: 10.1136/annrheumdis-2020-217659. Epub 2020 Apr 24. Ann Rheum Dis. 2022. PMID: 32332074 No abstract available.
-
Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a need for a more accurate control group?Ann Rheum Dis. 2022 May;81(5):e83. doi: 10.1136/annrheumdis-2020-217651. Epub 2020 Apr 27. Ann Rheum Dis. 2022. PMID: 32340976 No abstract available.
-
Response to 'Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura' by Xie and Zhang.Ann Rheum Dis. 2022 May;81(5):e82. doi: 10.1136/annrheumdis-2020-217694. Epub 2020 May 7. Ann Rheum Dis. 2022. PMID: 32381563 No abstract available.
-
Response to: 'Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a need for a more accurate control group?' by Mertz and Arnaud.Ann Rheum Dis. 2022 May;81(5):e84. doi: 10.1136/annrheumdis-2020-217696. Epub 2020 May 20. Ann Rheum Dis. 2022. PMID: 32434822 No abstract available.
-
Response to: 'Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: population-based cohort study' by Goulielmos and Zervou.Ann Rheum Dis. 2022 Jul;81(7):e113. doi: 10.1136/annrheumdis-2020-218177. Epub 2020 Jul 22. Ann Rheum Dis. 2022. PMID: 32699037 No abstract available.
-
Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: population-based cohort study.Ann Rheum Dis. 2022 Jul;81(7):e112. doi: 10.1136/annrheumdis-2020-218128. Epub 2020 Jul 22. Ann Rheum Dis. 2022. PMID: 32699040 No abstract available.
-
High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern.Ann Rheum Dis. 2022 Jul;81(7):e110. doi: 10.1136/annrheumdis-2020-218345. Epub 2020 Aug 21. Ann Rheum Dis. 2022. PMID: 32826277 No abstract available.
-
Response to: 'High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern?' by Inanc et al.Ann Rheum Dis. 2022 Jul;81(7):e111. doi: 10.1136/annrheumdis-2020-218402. Epub 2020 Sep 28. Ann Rheum Dis. 2022. PMID: 32988836 No abstract available.
-
High risk of systemic lupus erythematosus and antiphospholipic syndrome in patients with idiopathic thrombocytopenic purpura: Genetic aspects.Lupus. 2021 Jan;30(1):175-176. doi: 10.1177/0961203320972797. Epub 2020 Nov 11. Lupus. 2021. PMID: 33176567 No abstract available.
-
Response to: 'Correspondence on 'Risk of systemic lupus erythematosus after immune thrombocytopenia and autoimmune haemolytic anaemia: a nationwide French study'' by Maquet et al.Ann Rheum Dis. 2023 Apr;82(4):e96. doi: 10.1136/annrheumdis-2020-219583. Epub 2020 Dec 11. Ann Rheum Dis. 2023. PMID: 33310729 No abstract available.
-
Correspondence on 'Risk of systemic lupus erythematosus after immune thrombocytopenia and autoimmune haemolytic anaemia: a nationwide French study'.Ann Rheum Dis. 2023 Apr;82(4):e95. doi: 10.1136/annrheumdis-2020-219470. Epub 2020 Dec 11. Ann Rheum Dis. 2023. PMID: 33310730 No abstract available.
-
Response to: 'Correspondence on 'Risk of systemic lupus erythematosus after immune thrombocytopenia and autoimmune haemolytic anaemia: a nationwide French study'' by Maquet et al.Ann Rheum Dis. 2023 Apr;82(4):e97. doi: 10.1136/annrheumdis-2020-219582. Epub 2021 Jan 13. Ann Rheum Dis. 2023. PMID: 33441296 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
